Lumicera Receives URAC Specialty Pharmacy Accreditation

February 17, 2015

MADISON, Wis., February 17, 2015 – Lumicera Health Services, LLC, (Lumicera), a Wisconsin-based specialty pharmacy, announced today that it has been awarded full URAC accreditation for specialty pharmacy services (Specialty Pharmacy Accreditation, Version 2.0). URAC is an independent, nonprofit healthcare accrediting organization dedicated to promoting healthcare quality through accreditation, education and measurement. This is a 3-year accreditation, effective through June 1, 2017.

Open since February 2014, Lumicera is dedicated to improving specialty pharmacy care, one patient at a time, through educational, clinical, financial and service excellence. Lumicera is a wholly-owned subsidiary of Navitus Health Solutions, LLC, a Wisconsin-based pharmacy benefit manager.

“This accreditation is a significant accomplishment for us,” said Jamie Wong, Pharmacist-in-Charge at Lumicera. “Achieving specialty pharmacy accreditation validates our ongoing commitment to quality and continuous improvement.”

The URAC accreditation process demonstrates a commitment to quality services and serves as a framework to improve business processes through benchmarking organizations against nationally recognized standards.

“Lumicera’s achievement of URAC accreditation within the first year of opening demonstrates the companywide attention to quality,” noted Terry Seligman, President & CEO of Navitus. “Having gone through URAC accreditation reviews at Navitus, our staff has built policies and procedures to pass along best practices to Lumicera staff.”

“By applying for and receiving URAC accreditation, Navitus has demonstrated a commitment to quality healthcare,” said URAC President and CEO Kylanne Green. “Quality healthcare is crucial to our nation’s welfare and it is important to have organizations that are willing to measure themselves against national standards and undergo rigorous evaluation by an independent accrediting body.”

About Lumicera

Lumicera Health Services, LLC (Lumicera) is a full-service, URAC-accredited specialty pharmacy. Offering innovative specialty pharmacy solutions framed in the core principles of transparency and stewardship, Lumicera is dedicated to improving specialty pharmacy care, one patient at a time, through educational, clinical, financial and service excellence. Lumicera is a wholly-owned subsidiary of Navitus Health Solutions, LLC, a Wisconsin-based pharmacy benefit manager. Together, Navitus and Lumicera provide fully-integrated services and data integration to deliver best-in-class trend management. For more information about Lumicera’s tangible solutions to the rising cost of specialty drugs, visit www.lumicera.com or call 855-847-3554.

About URAC

URAC, an independent, nonprofit organization, is a well-known leader in promoting healthcare quality through its accreditation, education, and measurement programs. URAC offers a wide range of quality benchmarking programs and services that model the rapid changes in the healthcare system and provide a symbol of excellence for organizations to validate their commitment to quality and accountability. Through its broad-based governance structure and an inclusive standards development process, URAC ensures that all stakeholders are represented in establishing meaningful quality measures for the entire healthcare industry. For more information, visit www.urac.org.

Stay Informed and Connected

Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and more—straight to your inbox.

Examining Trends that Drive Informed Decisions

Now Available: 8th Annual Drug Trend Report

See the latest results and access industry insights you need to navigate current trend drivers.

Related blogs

Navigating Healthcare and Improving Outcomes

Real-world Data Demonstrates Successful Transitions from Humira to Biosimilars

Real-world Data Demonstrates Successful Transitions from Humira to Biosimilars

Authors: Justin Arzt, PharmD; Agata Siwak, PharmD, MSBA; Marnie Wickizer, PharmD, AE-C, CDCES; Ryan Schmidt, PharmD; Robert Topp, RN, PhD; Matt Hustad, PharmD All authors are employees of Navitus Health Solutions. Abstract Adalimumab biosimilar adoption…

PBM 101: Why the Model Matters

PBM 101: Why the Model Matters

In the pharmaceutical and healthcare industry, pharmacy benefit managers (PBMs) are conduits of expertise, analytics and savings opportunities, poised to deliver exceptional health care while driving down costs. They coordinate between drug manufacturers,…

Associate Resource Group Spotlight: Green Team

Associate Resource Group Spotlight: Green Team

The Green Team believes that small changes lead to significant impact. Whether its reducing waste, conserving energy or implementing eco-friendly initiatives, they serve as an internal hub for expertise regarding environmental sustainability….

PBM 101: The Three PBM Business Models

PBM 101: The Three PBM Business Models

In the pharmaceutical and healthcare industry, pharmacy benefit managers (PBMs) are regarded by the media as intermediaries between drug manufacturers, pharmacies, health plans and plan sponsors. But they’re so much more than that. PBMs act as conduits…

An Automated Approach to Diagnosis Verification of GLP-1 RA for Type 2 Diabetes Mellitus (T2DM)

An Automated Approach to Diagnosis Verification of GLP-1 RA for Type 2 Diabetes Mellitus (T2DM)

This study examines the impact of implementing an automated point-of-sale diagnosis verification system for glucagon-like peptide-1 receptor agonists (GLP-1 RAs) compared to traditional utilization management approaches….

Navitus to Remove Stelara® from Formulary July 1, 2025, Adds Biosimilars to Drive $120 Million in Savings 

Navitus to Remove Stelara® from Formulary July 1, 2025, Adds Biosimilars to Drive $120 Million in Savings 

As the nation’s first 100% transparent, pass-through PBM, we continue to advance medication affordability by prioritizing upfront, real-time savings over rebated models….

Achieving Outstanding Results with Tailored Network Strategies

Achieving Outstanding Results with Tailored Network Strategies

A medium-sized city in Michigan with 1,350 members was seeking ways to lower its pharmacy benefit costs, which were growing under its existing traditional pharmacy benefit manager (PBM). With its member covered by a two-tier, open formulary including…

Breaking Through Barriers with Value-Based Plan Design

Breaking Through Barriers with Value-Based Plan Design

Facing increased pharmacy benefit expenses, Blain’s Farm and Fleet, a Midwestern employer group, desired to improve plan performance. Specifically it was interested in educating eligible members about the benefits available to them, promoting cost-effective…

Finding a Solution to Lower Prescription Drug Costs

Finding a Solution to Lower Prescription Drug Costs

The Rural Arizona Group Health Trust (RAGHT) wanted to gain better control of its escalating drug trend with its large, traditional pharmacy benefit manager (PBM). Having only worked with traditional PBMs in the past, RAGHT was interested in exploring…

previous arrow
next arrow